Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
Brief Summary: The purpose of this study is to determine if treatment with Xionix will improve wound healing for patients with pyoderma gangrenosum.